Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Abaandou

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Medical Sciences (Basel, Switzerland)|June 13, 2018
Knocking out Ornithine Decarboxylase Antizyme 1 (<i>OAZ1</i>) Improves Recombinant Protein Expression in the HEK293 Cell LineLaura Abaandou, Joseph Shiloach
The Lancet. Diabetes & Endocrinology|January 27, 2025
The role of the hypothalamic-pituitary-thyroid axis in thyroid cancerLaura Abaandou, Raisa Ghosh, Joanna Klubo-Gwiezdzinska
Cells|August 7, 2021
Affecting HEK293 Cell Growth and Production Performance by Modifying the Expression of Specific GenesLaura Abaandou, David Quan, Joseph Shiloach
Biotechnology and Bioengineering|September 10, 2020
Knockout of the caspase 8-associated protein 2 gene improves recombinant protein expression in HEK293 cells through up-regulation of the cyclin-dependent kinase inhibitor 2A geneLaura Abaandou, Ashish K Sharma, Joseph Shiloach
New Biotechnology|August 20, 2019
Improved protein expression in HEK293 cells by over-expressing miR-22 and knocking-out its target gene, HIPK1Sarah Inwood, Laura Abaandou, Michael Betenbaugh, et al.
Protein Expression and Purification|February 19, 2022
Expression and production of pigment epithelium-derived factor (PEDF) and PEDF receptor variants from mammalian and bacterial cellsJeanee Bullock, Federica Polato, Daniel C Lulli, et al.
Plos One|June 14, 2013
Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia modelHatice Karauzum, Rajan P Adhikari, Jawad Sarwar, et al.
Plos One|June 16, 2012
Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumoniaRajan P Adhikari, Hatice Karauzum, Jawad Sarwar, et al.
Scientific Reports|March 3, 2019
TBA<sub>225</sub>, a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigensArundhathi Venkatasubramaniam, Rajan P Adhikari, Thomas Kort, et al.
The Journal of Biological Chemistry|May 31, 2012
Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndromeHatice Karauzum, Gang Chen, Laura Abaandou, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Medical Sciences (Basel, Switzerland)|June 13, 2018
Knocking out Ornithine Decarboxylase Antizyme 1 (<i>OAZ1</i>) Improves Recombinant Protein Expression in the HEK293 Cell LineLaura Abaandou, Joseph Shiloach
The Lancet. Diabetes & Endocrinology|January 27, 2025
The role of the hypothalamic-pituitary-thyroid axis in thyroid cancerLaura Abaandou, Raisa Ghosh, Joanna Klubo-Gwiezdzinska
Cells|August 7, 2021
Affecting HEK293 Cell Growth and Production Performance by Modifying the Expression of Specific GenesLaura Abaandou, David Quan, Joseph Shiloach
Biotechnology and Bioengineering|September 10, 2020
Knockout of the caspase 8-associated protein 2 gene improves recombinant protein expression in HEK293 cells through up-regulation of the cyclin-dependent kinase inhibitor 2A geneLaura Abaandou, Ashish K Sharma, Joseph Shiloach
New Biotechnology|August 20, 2019
Improved protein expression in HEK293 cells by over-expressing miR-22 and knocking-out its target gene, HIPK1Sarah Inwood, Laura Abaandou, Michael Betenbaugh, et al.
Protein Expression and Purification|February 19, 2022
Expression and production of pigment epithelium-derived factor (PEDF) and PEDF receptor variants from mammalian and bacterial cellsJeanee Bullock, Federica Polato, Daniel C Lulli, et al.
Plos One|June 14, 2013
Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia modelHatice Karauzum, Rajan P Adhikari, Jawad Sarwar, et al.
Plos One|June 16, 2012
Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumoniaRajan P Adhikari, Hatice Karauzum, Jawad Sarwar, et al.
Scientific Reports|March 3, 2019
TBA<sub>225</sub>, a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigensArundhathi Venkatasubramaniam, Rajan P Adhikari, Thomas Kort, et al.
The Journal of Biological Chemistry|May 31, 2012
Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndromeHatice Karauzum, Gang Chen, Laura Abaandou, et al.
Pageof 2